[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350839-105":59,"doc-detail-350839-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","pegylated-chitosan-nanoparticles-engineering-multifunctional-platforms-for-targeted-cervical-and-lung-cancer-treatment","PEGylated Chitosan Nanoparticles - Engineering Multifunctional Platforms for Targeted Cervical and Lung Cancer Treatment","","Polymer-based nanocarriers have emerged as transformative platforms in cancer nanomedicine, enabling controlled and site-specific delivery of therapeutic agents. Chitosan, a polysaccharide-derived biopolymer, is valued for biodegradability, biocompatibility, and mucoadhesive behavior that supports drug encapsulation and cellular internalization. Surface PEGylation further improves colloidal stability, circulation persistence, and immune recognition reduction, while ligand-mediated design enables active tumor targeting and selective intracellular delivery. This review summarizes advances in PEGylated chitosan nanoparticle design, pharmacokinetics, release mechanisms, anticancer performance, and ongoing translational challenges and safety considerations.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pegylated-chitosan-nanoparticles-engineering-multifunctional-platforms-for-targeted-cervical-and-lung-cancer-treatment/350839/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pegylated-chitosan-nanoparticles-engineering-multifunctional-platforms-for-targeted-cervical-and-lung-cancer-treatment/350839.png","ImageObject",300,407,{"name":92,"@type":93},"moss~","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why are chitosan nanoparticles considered promising for cancer drug delivery?","Question",{"text":113,"@type":114},"Chitosan nanoparticles provide biodegradability and biocompatibility, and their mucoadhesive and drug-encapsulation capabilities support efficient delivery while potentially reducing systemic toxicity compared with conventional chemotherapy.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does PEGylation improve the performance of chitosan nanoparticles?",{"text":118,"@type":114},"PEGylation enhances colloidal stability, extends systemic circulation by protecting nanoparticles in biological environments, and reduces opsonization/recognition by the reticuloendothelial system, thereby improving bioavailability and efficacy.",{"name":120,"@type":111,"acceptedAnswer":121},"What role does ligand-mediated functionalization play in targeted cancer treatment?",{"text":122,"@type":114},"Ligand-mediated functionalization enables active tumor targeting and selective intracellular delivery, which can improve therapeutic efficacy while minimizing off-target toxicity.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},350839,1790187592,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":41,"preview_page_count":19,"preview_urls":146},962090895452,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Cancer Science  \nPEGylated Chitosan Nanoparticles: Engineering Multifunctional Platforms for Targeted Cervical and Lung Cancer Treatment  \nPrashant Kesharwani1,2,3  | Nazim Nasir4 | Shadma Wahab5 | Garima Gupta6,7 | Khang Wen Goh8 | Amirhossein Sahebkar9   \n1Next-Generation Translational Nanomedicine Laboratory, Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar, Madhya Pradesh, India | 2Department of Research and Development, Asia University, Taichung, Taiwan | 3University Institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, India | 4Department of Basic Medical Sciences, College of Applied Medical Sciences, Khamis Mushait, King Khalid University, Abha, Saudi Arabia | 5Department of Pharmacognosy, College of Pharmacy, King Khalid University, Abha, Saudi Arabia | 6Graphic Era Hill University, Dehradun, India | 7School of Allied Medical Sciences, Lovely Professional University, Phagwara, Punjab, India | 8Faculty of Data Science and Information Technology, INTI International University, Nilai, Malaysia | 9Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran  \nCorrespondence: Prashant Kesharwani ([prashantdops@gmail.com](prashantdops@gmail.com)) | Amirhossein Sahebkar ([amir_saheb2000@yahoo.com](amir_saheb2000@yahoo.com))  \nReceived: 21 December 2025 | Revised: 24 February 2026 | Accepted: 26 February 2026  \nKeywords: biopolymer modification | cancer nanomedicine | clinical translation | controlled release | PEGylated chitosan nanoparticles | targeted drug delivery | tumor targeting  \nABSTRACT  \nPolymer-based nanocarriers have emerged as transformative platforms in cancer nanomedicine, enabling controlled and sitespecific delivery of therapeutic agents. Among polysaccharide-derived materials, chitosan stands out for its biodegradability, biocompatibility, and intrinsic mucoadhesive properties that promote efficient drug encapsulation and enhanced cellular internalization. Surface PEGylation the conjugation of polyethylene glycol (PEG) chains further augments the physicochemical and biological performance of chitosan nanoparticles by enhancing colloidal stability, extending systemic circulation, and reducing opsonization by the reticuloendothelial system. In addition, ligand-mediated functionalization facilitates active tumor targeting and selective intracellular delivery, thereby improving therapeutic efficacy while minimizing off-target toxicity. This review critically summarizes recent advances in the design, synthesis, and functional modification of PEGylated chitosan nanoparticles, with emphasis on their pharmacokinetic behavior, drug release mechanisms, and anticancer performance. Comparative insights into other polymeric and lipid-based nanocarrier systems are also provided. Finally, current challenges, safety considerations, and translational perspectives are discussed, underscoring the promise of PEGylated chitosan nanoplatforms as next-generation biomaterials for precision oncology.  \n1 | Introduction  \nChitosan nanoparticles (NPs) unique properties and capabilities have shown promise in cancer treatment [1] . Chitosan, a  \nbiopolymer that originates from chitin present in crustacean exoskeletons, exhibits biodegradability and biocompatibility, making it particularly suitable for drug delivery application [2] . It was observed that the body can easily absorb chitosan, and it  \n\n| Abbreviations: CH, chitosan; DHFR, dihydrofolate reductase; DLS, dynamic light scattering; EPR, enhanced permeability and retention; FA, folic acid; MMC, mitomycin; mPEG, methoxypoly (ethylene glycol); MTX, methotrexate; NPs, nanoparticles; SEM, scanning electron microscopy; TEM, transmission electron microscopy. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the origin","cbCaiopDKHzUbaKT","https://ap.wps.com/l/cbCaiopDKHzUbaKT","pdf",1454061,12,"English","# Introduction\n## Chitosan nanoparticles in cancer therapy\n## PEGylated chitosan nanoparticles: rationale and benefits","[{\"question\":\"Why are chitosan nanoparticles considered promising for cancer drug delivery?\",\"answer\":\"Chitosan nanoparticles provide biodegradability and biocompatibility, and their mucoadhesive and drug-encapsulation capabilities support efficient delivery while potentially reducing systemic toxicity compared with conventional chemotherapy.\"},{\"question\":\"How does PEGylation improve the performance of chitosan nanoparticles?\",\"answer\":\"PEGylation enhances colloidal stability, extends systemic circulation by protecting nanoparticles in biological environments, and reduces opsonization/recognition by the reticuloendothelial system, thereby improving bioavailability and efficacy.\"},{\"question\":\"What role does ligand-mediated functionalization play in targeted cancer treatment?\",\"answer\":\"Ligand-mediated functionalization enables active tumor targeting and selective intracellular delivery, which can improve therapeutic efficacy while minimizing off-target toxicity.\"}]","PEGylated Chitosan Nanoparticles - Engineering Multifunctional Platforms for Targeted Cervical and Lung Cancer Treatment | PDF",1790091385,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4176408ca7ad7c3b6cdd2db86dde2874.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1ca3ffc9481e006d3c355bf2da90e550.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5aac393b7a5d00bec529d052bd6650cc.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/25c177e53789e65514dc7bfac85b178a.webp",980,1287]